Another clinical study of 414 HCC patients in Anhui, China, aimed to evaluate the prognostic significance of serum AST/ALT and GGT levels revealed that ALT, AST, and GGT were potential indicators of liver cancer progression [18]. The gene discussed is GPT; the disease is liver cancer.